Turanabol 10 mg

package leaflet: information for the user / patient
turanabol 10 mg film-coated tablets
clordehidrometiltestosteron

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
– Keep this leaflet. You may need to read it again.
– If you have any further questions, ask your doctor or pharmacist or nurse.
– This medicine has been prescribed for you only. You do not have to give it to others. It can hurt them, even if they have the same signs of illness as yours.
– If you have any side effects, talk to your doctor or pharmacist or nurse. These include any possible side effects not mentioned in this leaflet. See section 4.

What you find in this leaflet:
1. What Turanabol is and what it is used for
2. What you need to know before you use Turanabol
3. How to use Turanabol
4. Possible side effects
5. How to store Turanabol
6. Packaging content and other information

1. What Turanabol is and what it is used for
Turanabol tablets are used during recovery in pathologies accompanied by protein synthesis disruptions (diverse cachexia genesis, trauma, extensive burns, condition after infectious diseases and irradiation, muscular dystrophy, osteoporosis) in corticosteroid therapy, hypoplastic and aplastic anemia, chronic hemolytic anemia, anemia of chronic renal failure, lymphomas and leukemia, thrombocytopenia idiopathic.

2. What you need to know before you use Turanabol
Do not use Turanabol:
– if you are allergic (hypersensitive) to the active substance or any of the other ingredients of Turanabol;
– if you are pregnant or breast-feeding;
– additional contraindications are prostate carcinoma, mammary carcinoma in men, female breast cancer, ovarian cancer, ischemic cardiopathy, severe atherosclerosis, hepatic and renal failure, nephritis, nephrotic syndrome, acute and chronic prostatitis.
Warnings and precautions
It is forbidden to overdose recommended doses. When administering the preparation to women, the expected benefit and the possible risk of treatment should be evaluated considering the androgenic effect of the preparation. When the first signs of virilization of the patients (voice thickening, hirsutism, acne, clitoromalgia) occur, administration should be stopped to avoid irreversible changes.
Preparations in this group may cause the suppression of blood coagulation factors that require careful monitoring, including concomitant use with anticoagulants.
The preparation is administered with caution to patients with impaired heart function, hypertension, impaired hepatic and renal function, epilepsy, migraine and glaucoma (intraocular tension), including a history. During treatment, systematic control of intraocular pressure is recommended due to possible retention of sodium and water ions in the body. Possible changes in liver function, so after a 4-week treatment schedule, it is recommended to monitor liver function.
An increase in the incidence of hypertrophy and prostate carcinoma in the elderly may require a rigorous control. Before initiating the treatment and later on, prostate rectal control is recommended during the treatment.
In diabetes, it is advisable to adjust the doses of anti-hyperglycaemic agents.
In patients with malignant tumors the duration of treatment will be determined individually and according to liver parameters. Systemically control lipidemia and cholesterol.
During treatment with Turanabol it is recommended to provide adequate food, protein, lipid, carbohydrate, vitamins and minerals.
Children and adolescents
Turanabol tablets are not recommended for children and adolescents below the age of 18 due to a lack of data on the safety and efficacy of the preparation in these age groups.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Other medicines (blood glucose lowering medicines called antidiabetic medicines and so-called coumarin derivatives used to prevent blood clotting) may influence the effect of Turanabol. Turanabol may potentiate the hepatotoxic effect of some medicines.
Also drugs from glucocorticoid group, mineralocorticoids, sodium-containing preparations and high-sodium foods potentiate fluid retention in the body, increase the risk of developing edema, intensify acne eruptions.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any medicine. Turanabol should not be used during pregnancy and breast-feeding.
Driving and using machines
Turanabol treatment has no influence on the ability to drive and use machines.
Important information about some of the ingredients of Turanabol
Turanabol tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency (Lapp), or glucose-galactose malabsorption should not take this medicine.
Turanabol tablets contain FD @ C Yellow N6 (E110) dye, which can cause allergic reactions.

3. How to use Turanabol
Turanabol should always be used in the dose, mode and duration prescribed by your doctor.
Response to treatment can be varied and doses adjusted individually. The dose of Turanabol for adults per day is 20-50 mg. The length of the cure is considered adequate for 2 to 6 weeks.
Method of administration
It is given orally. The coated tablets should be swallowed whole with a sufficient amount of liquid. The tablets should not be divided, broken or chewed.
If you have used more Turanabol than you should
If you have taken or think you have taken more Turanabol tablets than you should (overdose), tell your doctor straight away or get to your nearest medical unit. Bring the package or the medicines left with you.
Cases of overdose have not been reported. In the case of abuse of preparations containing chlor-dehdromethyl-testosterone (high doses as anabolic remedy) severe endocrine, metabolic and psychiatric adverse reactions are reported.
If you forget to take Turanabol
If you forget to take a dose, take the missed dose as soon as you remember.
However, if time for next dose approaches, stop taking the omitted dose. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on this medicine, ask your doctor or pharmacist.
If you stop taking Turanabol
You must continue to use Turanabol as long as your doctor tells you. Do not stop taking the medicine without first talking to your doctor or pharmacist. If you have any further questions on this medicine, ask your doctor or pharmacist.

4. Possible side effects
Like all medicines, Turanabol can cause side effects, although not everybody gets them.
Turanabol tablets in therapeutic doses are unlikely to causes side effects. During the prolonged treatment, the following side effects (no frequency data available) were observed:
– liver tumors in the elderly hypertrophy and / or prostate carcinoma;
– changes in blood analysis, low blood clotting with bleeding tendency;
– hypersensitivity reactions;
– excitation, insomnia, depression, confusion;
– suppressing sexual stimulation hormone secretion;
– in women – the appearance of signs of virilization (for example acne, hirsutism, male alopecia, irreversible thickening of the voice of the voice, dysmenorrhea, clitoral hypertrophy), hasting may be the first sign of change in tone, which may be long lasting, and sometimes irreversible;
– lack of menstrual cycle and inhibition of spermatogenesis;
– enlargement of mammary glands in men;
– libido modification;
– fluid retention with peripheral edema, hypercalcemia (increase of calcium ions in the blood) in men and women – progression of atherosclerosis (pathology of fat deposition on intima vessels called arteries);
– nausea, vomiting, decreased appetite;
– liver dysfunction, cholestasis (difficulty in releasing the bile), jaundice (yellowing of the tegument);
– acne, hirsutism (abnormal hair growth) insignificant;
– retention of sodium and water ions in the body;
– increased blood biochemical parameters (blood urea, positive nitrate balance, hypercalcemia), especially in bed care patients, and in patients with metastatic breast cancer;
– change (increase) in liver function indices;
– pain in the bones;
– bladder irritation;
– priapism.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Reporting adverse reactions
If you experience any side effects, talk to your doctor or pharmacist. These include any possible side effects not mentioned in this leaflet. By reporting side effects, you can help provide additional information on the safety of this medicine.

5. How to store Turanabol
Keep out of the reach and sight of children.
Keep protected from light and temperatures below 25 °C.
Do not use Turanabol after the expiry date which is stated on the carton after “EXP”. The expiration date refers to the last day of that month.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer need. These measures will help to protect the environment.

6. Packaging content and other information
What Turanabol contains
The active substance is chlorodihydrolyltestosterone.
1 film-coated tablet contains 10 mg of chloddehydronetestosterone.
The other ingredients are:
Core
magnesium stearate, Kollidon CL (crospovidone), Ludipress (lactose monohydrate, polyvidone, crospovidone).
Coat
copolymer of polyvinyl alcohol and polyethylene glycol, talc, titanium dioxide, mono and diglycerides of fatty acids, polyvinyl alcohol, FD & C dye Yellow No. 6 (E110), quinoline yellow dye.
What Turanabol looks like and contents of the pack
Yellow, biconvex, film-coated tablets. In cross section, the internal contents of the tablet are white.
The contents of the packaging
Turanabol 10 mg film-coated tablets.
Twenty-five (25) film-coated tablets are packing in a PVC / Al blister.
Four (4) blister packs together with the patient leaflet are placed in a carton.

CERTIFICATE OF REGISTRATION
SC Balkan Pharmaceuticals SRL N. Grădescu str., 4, MD-2002, or. Chisinau, Republic of Moldova.
The manufacturer
SC Balkan Pharmaceuticals SRL Industrial Street, 7 / A, MD-2091, or. Singera, Republic of Moldova.

This product you can buy now.